Balyasny Asset Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-59,879
| Closed | -$1.65M | – | 2180 |
|
|
2024
Q3 | $1.65M | Buy |
59,879
+10,612
| +22% | +$293K | ﹤0.01% | 1185 |
|
|
2024
Q2 | $1.43M | Buy |
49,267
+37,429
| +316% | +$1.09M | ﹤0.01% | 1144 |
|
|
2024
Q1 | $528K | Buy |
+11,838
| New | +$528K | ﹤0.01% | 1455 |
|
|
2022
Q4 | – | Sell |
-1,675
| Closed | -$245K | – | 2559 |
|
|
2022
Q3 | $245K | Buy |
+1,675
| New | +$245K | ﹤0.01% | 1781 |
|
|
2022
Q2 | – | Sell |
-3,388
| Closed | -$342K | – | 2522 |
|
|
2022
Q1 | $342K | Buy |
+3,388
| New | +$342K | ﹤0.01% | 1548 |
|
|
2021
Q4 | – | Sell |
-6,427
| Closed | -$1.9M | – | 2189 |
|
|
2021
Q3 | $1.9M | Buy |
+6,427
| New | +$1.9M | 0.01% | 959 |
|